Works matching AU Lesokhin, A.

Results: 47

Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01048-0
By:
- Costa, Bruno Almeida;
- Flynn, Jessica;
- Nishimura, Noriko;
- Devlin, Sean M.;
- Farzana, Tasmin;
- Rajeeve, Sridevi;
- Chung, David J.;
- Landau, Heather J.;
- Lahoud, Oscar B.;
- Scordo, Michael;
- Shah, Gunjan L.;
- Hassoun, Hani;
- Maclachlan, Kylee;
- Hultcrantz, Malin;
- Korde, Neha;
- Lesokhin, Alexander M.;
- Shah, Urvi A.;
- Tan, Carlyn R.;
- Giralt, Sergio A.;
- Usmani, Saad Z.
Publication type:
Article
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00879-7
By:
- Raje, Noopur;
- Anderson, Kenneth;
- Einsele, Hermann;
- Efebera, Yvonne;
- Gay, Francesca;
- Hammond, Sarah P.;
- Lesokhin, Alexander M.;
- Lonial, Sagar;
- Ludwig, Heinz;
- Moreau, Philippe;
- Patel, Krina;
- Ramasamy, Karthik;
- Mateos, Maria-Victoria
Publication type:
Article
Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00882-y
By:
- Tan, Carlyn Rose;
- Derkach, Andriy;
- Nemirovsky, David;
- Ciardiello, Amanda;
- Diamond, Benjamin;
- Hultcrantz, Malin;
- Hassoun, Hani;
- Mailankody, Sham;
- Shah, Urvi;
- Maclachlan, Kylee;
- Patel, Dhwani;
- Lahoud, Oscar B.;
- Landau, Heather J.;
- Chung, David J.;
- Shah, Gunjan L.;
- Scordo, Michael;
- Giralt, Sergio A.;
- Lesokhin, Alexander;
- Usmani, Saad Z.;
- Landgren, Ola
Publication type:
Article
Extreme body mass index and survival in newly diagnosed multiple myeloma patients.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00782-7
By:
- Shah, Urvi A.;
- Whiting, Karissa;
- Devlin, Sean;
- Ershler, Rachel;
- Kanapuru, Bindu;
- Lee, David J.;
- Tahri, Sabrin;
- Gwise, Thomas;
- Rustad, Even H.;
- Mailankody, Sham;
- Lesokhin, Alexander M.;
- Kazandjian, Dickran;
- Maura, Francesco;
- Auclair, Daniel;
- Birmann, Brenda M.;
- Usmani, Saad Z.;
- Gormley, Nicole;
- Marinac, Catherine R.;
- Landgren, Ola
Publication type:
Article
Nutrition perceptions, needs and practices among patients with plasma cell disorders.
Published in:
2022
By:
- Malik, Maria A.;
- Sweeney, Nathan W.;
- Jafri, Mohammad;
- Derkach, Andriy;
- Chmielewski, Cynthia;
- Adintori, Peter A.;
- Mailankody, Sham;
- Korde, Neha;
- Tan, Carlyn R.;
- Hassoun, Hani;
- Hultcrantz, Malin;
- Hillengass, Jens;
- McCann, Susan E.;
- Iyengar, Neil;
- Usmani, Saad;
- Giralt, Sergio A.;
- Landgren, Ola;
- van den Brink, Marcel R. M.;
- Ahlstrom, Jennifer M.;
- Lesokhin, Alexander M.
Publication type:
Letter
Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 8, p. 1033, doi. 10.1038/bmt.2012.281
By:
- Pozotrigo, M;
- Adel, N;
- Landau, H;
- Lesokhin, A;
- Lendvai, N;
- Chung, D J;
- Chimento, D;
- Riedel, E;
- Chen, X;
- Reich, L;
- Comenzo, R;
- Giralt, S;
- Hassoun, H
Publication type:
Article
Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantation.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 3, p. 419, doi. 10.1038/bmt.2012.151
By:
- Zamarin, D;
- Giralt, S;
- Landau, H;
- Lendvai, N;
- Lesokhin, A;
- Chung, D;
- Koehne, G;
- Chimento, D;
- Devlin, S M;
- Riedel, E;
- Bhutani, M;
- Babu, D;
- Hassoun, H
Publication type:
Article
P-216: Daratumumab, Carfilzomib, Lenalidomide, & Dexamethasone for relapsed/refractory Myeloma with salvage autologous hematopoietic cell transplant: interim analysis of the multicenter 2nd chance protocol.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S158, doi. 10.1016/S2152-2650(21)02343-0
By:
- Gunjan Shah;
- Bal, Susan;
- Rodriguez, Cesar;
- Chhabra, Saurabh;
- Bayer, Ruthee;
- Costa, Luciano;
- Lambird, Jonathan;
- Ferrer, Christine;
- Parascondola, Allison;
- Marcello, Leeann;
- Shulman, Leah;
- Obadi, Obadi;
- Acosta, Jennifer;
- Hassoun, Hani;
- Hultcrantz, Malin;
- Korde, Neha;
- Mailankody, Sham;
- Tan, Carlyn;
- Shah, Urvi;
- Lesokhin, Alexander
Publication type:
Article
P-152: Providing nutritional guidance for patients with plasma cell disorders – a missed opportunity for hematologists and oncologists?
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S118, doi. 10.1016/S2152-2650(21)02279-5
By:
- Sweeney, Nathan;
- Malik, Maria;
- Jafri, Mohammad;
- Derkach, Andriy;
- Chmielewski, Cynthia;
- Adintori, Peter;
- Mailankody, Sham;
- Neha Korde;
- Tan, Carlyn;
- Hani Hassoun;
- Hultcrantz, Malin;
- Hillengass, Jens;
- McCann, Susan;
- Iyengar, Neil;
- Giralt, Sergio;
- Landgren, Ola;
- van den Brink, Marcel;
- Ahlstrom, Jenny;
- Lesokhin, Alexander;
- D'Souza, Anita
Publication type:
Article
OAB-026: MagnetisMM-1 study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA) targeted CD3-engaging bispecific molecule, for patients (pts) with relapsed or refractory multiple myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S17, doi. 10.1016/S2152-2650(21)02100-5
By:
- Dholaria, Bhagirathbhai;
- Bahlis, Nizar;
- Raje, Noopur;
- Costello, Caitlin;
- Solh, Melhem;
- Levy, Moshe;
- Tomasson, Michael;
- Dube, Harman;
- Damore, Michael;
- Hoi Kei Lon;
- Basu, Cynthia;
- Skoura, Athanasia;
- Chan, Edward;
- Trudel, Suzanne;
- Jakubowiak, Andrzej;
- Chu, Michael;
- Gasparetto, Cristina;
- Dalovisio, Andrew;
- Sebag, Michael;
- Lesokhin, Alexander
Publication type:
Article
MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S439, doi. 10.1016/S2152-2650(21)01978-9
By:
- Levy, Moshe;
- Bahlis, Nizar;
- Raje, Noopur;
- Costello, Caitlin;
- Dholaria, Bhagirathbhai;
- Solh, Melhem;
- Tomasson, Michael;
- Dube, Harman;
- Damore, Michael;
- Hoi Kei Lon;
- Basu, Cynthia;
- Skoura, Athanasia;
- Chan, Edward;
- Trudel, Suzanne;
- Jakubowiak, Andrzej;
- Chu, Michael;
- Gasparetto, Cristina;
- Dalovisio, Andrew;
- Sebag, Michael;
- Lesokhin, Alexander
Publication type:
Article
Poster: MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01578-0
By:
- Levy, Moshe;
- Bahlis, Nizar;
- Raje, Noopur;
- Costello, Caitlin;
- Dholaria, Bhagirathbhai;
- Solh, Melhem;
- Tomasson, Michael;
- Dube, Harman;
- Damore, Michael;
- Lon, Hoi Kei;
- Basu, Cynthia;
- Skoura, Athanasia;
- Chan, Edward;
- Trudel, Suzanne;
- Jakubowiak, Andrzej;
- Chu, Michael;
- Gasparetto, Cristina;
- Dalovisio, Andrew;
- Sebag, Michael;
- Lesokhin, Alexander
Publication type:
Article
Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.
Published in:
2020
By:
- Salcedo, Meghan;
- Lendvai, Nikoletta;
- Mastey, Donna;
- Schlossman, Julia;
- Hultcrantz, Malin;
- Korde, Neha;
- Mailankody, Sham;
- Lesokhin, Alexander;
- Hassoun, Hani;
- Smith, Eric;
- Shah, Urvi;
- Diab, Victoria;
- Werner, Kelly;
- Landau, Heather;
- Lahoud, Oscar;
- Drullinsky, Pamela;
- Shah, Gunjan;
- Chung, David;
- Scordo, Michael;
- Giralt, Sergio
Publication type:
clinical trial
Depth of Response and Outcomes by Initial Therapy Prior to Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e298, doi. 10.1016/j.clml.2019.09.490
By:
- Shah, Gunjan;
- Chung, David;
- Scordo, Michael;
- Seier, Kenneth;
- Hassoun, Hani;
- Hultcrantz, Malin;
- Korde, Neha;
- Lesokhin, Alexander;
- Mailankody, Sham;
- Shah, Urvi;
- Smith, Eric;
- Mezzi, Khalid;
- Welliver, Timothy;
- Braunlin, Megan;
- Werther, Winifred;
- Delgado, Ruby;
- Bashir, Qaiser;
- Srour, Samer;
- Landgren, C. Ola;
- Landau, Heather
Publication type:
Article
Practice Patterns with Focal Progression on Daratumumab Therapy.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e142, doi. 10.1016/j.clml.2019.09.237
By:
- Bal, Susan;
- Peterson, Tim;
- Landau, Heather;
- Chung, David;
- Giralt, Sergio;
- Korde, Neha;
- Mailankody, Sham;
- Smith, Eric;
- Shah, Urvi;
- Hultcrantz, Malin;
- Hassoun, Hani;
- Landgren, C. Ola;
- Lesokhin, Alexander
Publication type:
Article
Stem Cell Mobilization and Autograft Purity with Novel Induction Regimens in Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e46, doi. 10.1016/j.clml.2019.09.070
By:
- Bal, Susan;
- Landau, Heather;
- Shah, Gunjan;
- Scordo, Michael;
- Dahi, Parastoo;
- Lahoud, Oscar;
- Hassoun, Hani;
- Hultcrantz, Malin;
- Korde, Neha;
- Lesokhin, Alexander;
- Lendvai, Nikoletta;
- Mailankody, Sham;
- Landgren, C. Ola;
- Smith, Eric;
- Giralt, Sergio;
- Chung, David
Publication type:
Article
Galinpepimut-S, a WT1-Targeting Immuno-Oncology Treatment, Induces Specific, Robust and Durable Immune Responses (IRs) in Patients (Pts) with High-Risk (HR) Multiple Myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S343, doi. 10.1016/j.clml.2017.07.164
By:
- Koehne, Guenther;
- Devlin, Sean;
- Korde, Neha;
- Mailankody, Sham;
- Heather, Landau;
- Hassoun, Hani;
- Lesokhin, Alexander;
- Lendvai, Nikoletta;
- Chung, David;
- Sarlis, Nicholas;
- Giralt, Sergio;
- Landgren, Ola
Publication type:
Article
Re-immunization following Autologous Hematopoietic Stem Cell Transplantation (Auto HCT) is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e82, doi. 10.1016/j.clml.2017.03.149
By:
- Shah, Gunjan;
- Palazzo, Meighan;
- Copelan, Olivia;
- Seier, Kenneth;
- Devlin, Sean;
- Hassoun, Hani;
- Korde, Neha;
- Lendvai, Nikoletta;
- Lesokhin, Alexander;
- Mailankody, Sham;
- Chung, David;
- Koehne, Guenther;
- Landgren, C. Ola;
- Landau, Heather;
- Giralt, Sergio;
- Perales, Miguel-Angel
Publication type:
Article
Improvement of Response for Multiple Myeloma patients on Lenalidomide Maintenance after Autologous Hematopoietic Stem Cell Transplantation (Auto HCT).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e140, doi. 10.1016/j.clml.2017.03.253
By:
- Shah, Gunjan;
- Assal, Amer;
- Hsu, Meier;
- Devlin, Sean;
- Hassoun, Hani;
- Korde, Neha;
- Lendvai, Nikoletta;
- Lesokhin, Alexander;
- Mailankody, Sham;
- Smith, Eric;
- Chung, David;
- Koehne, Guenther;
- Landgren, C. Ola;
- Landau, Heather;
- Giralt, Sergio
Publication type:
Article
Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study.
Published in:
Cancer Medicine, 2023, v. 12, n. 9, p. 10254, doi. 10.1002/cam4.5753
By:
- Lesokhin, Alexander;
- LeBlanc, Richard;
- Dimopoulos, Meletios A.;
- Capra, Marcelo;
- Carlo‐Stella, Carmelo;
- Karlin, Lionel;
- Castilloux, Jean‐Francois;
- Forsberg, Peter;
- Parmar, Gurdeep;
- Tosikyan, Axel;
- Pour, Ludek;
- Ribrag, Vincent;
- Ribolla, Rossella;
- Abdallah, Al‐Ola;
- Le Roux, Nadia;
- Dong, Liyan;
- van de Velde, Helgi;
- Mayrargue, Laurent;
- Lépine, Lucie;
- Macé, Sandrine
Publication type:
Article
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25469-8
By:
- Maclachlan, Kylee H.;
- Rustad, Even H.;
- Derkach, Andriy;
- Zheng-Lin, Binbin;
- Yellapantula, Venkata;
- Diamond, Benjamin;
- Hultcrantz, Malin;
- Ziccheddu, Bachisio;
- Boyle, Eileen M.;
- Blaney, Patrick;
- Bolli, Niccolò;
- Zhang, Yanming;
- Dogan, Ahmet;
- Lesokhin, Alexander M.;
- Morgan, Gareth J.;
- Landgren, Ola;
- Maura, Francesco
Publication type:
Article
Enhancing T‐cell responses to GCB‐like lymphomas with immune‐checkpoint‐blockade‐based therapies.
Published in:
Hematological Oncology, 2023, v. 41, p. 280, doi. 10.1002/hon.3164_192
By:
- Serganova, I.;
- Bucktrout, R.;
- Isshiki, Y.;
- Sarapulov, A.;
- Santella, A.;
- Rodriguez, M.;
- Chakraborty, S.;
- Brunschvig, S.;
- Qualls, D.;
- Vardhana, S.;
- Lesokhin, A.;
- Melnick, A.;
- Beguelin, W.;
- Zappasodi, R.
Publication type:
Article
The Effect of Volume-Change-Induced Stresses on the Morphological Stability of the Interface Boundary in a Ternary Diffusion Couple.
Published in:
Physica Status Solidi (B), 1997, v. 201, n. 2, p. 389, doi. 10.1002/1521-3951(199706)201:2<389::AID-PSSB389>3.0.CO;2-#
By:
- Lesokhin, S.;
- Levin, L.
Publication type:
Article
Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance.
Published in:
Leukemia (08876924), 2013, v. 27, n. 12, p. 2422, doi. 10.1038/leu.2013.126
By:
- Zamarin, D;
- Devlin, S M;
- Arcila, M E;
- Landau, H;
- Lesokhin, A;
- Lendvai, N;
- Chung, D J;
- Chimento, D;
- Weltz, J;
- Babu, D;
- Giralt, S;
- Hassoun, H
Publication type:
Article
On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation.
Published in:
Science Translational Medicine, 2015, v. 7, n. 280, p. 1, doi. 10.1126/scitranslmed.3010274
By:
- Lesokhin, Alexander M.;
- Callahan, Margaret K.;
- Postow, Michael A.;
- Wolchok, Jedd D.
Publication type:
Article
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis.
Published in:
British Journal of Haematology, 2022, v. 196, n. 1, p. 105, doi. 10.1111/bjh.17772
By:
- Piedra, Katrina;
- Peterson, Tim;
- Tan, Carlyn;
- Orozco, Jennifer;
- Hultcrantz, Malin;
- Hassoun, Hani;
- Mailankody, Sham;
- Lesokhin, Alexander;
- Shah, Urvi;
- Lu, Sydney;
- Patel, Dhwani;
- Derkach, Andriy;
- Wilkins, Cy R.;
- Korde, Neha
Publication type:
Article
Comparison of MALDI‐TOF mass spectrometry analysis of peripheral blood and bone marrow‐based flow cytometry for tracking measurable residual disease in patients with multiple myeloma.
Published in:
British Journal of Haematology, 2020, v. 189, n. 5, p. 904, doi. 10.1111/bjh.16443
By:
- Eveillard, Marion;
- Rustad, Even;
- Roshal, Mikhail;
- Zhang, Yanming;
- Ciardiello, Amanda;
- Korde, Neha;
- Hultcrantz, Malin;
- Lu, Sydney;
- Shah, Urvi;
- Hassoun, Hani;
- Smith, Eric;
- Lesokhin, Alexander;
- Mailankody, Sham;
- Landgren, Ola;
- Thoren, Katie
Publication type:
Article
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma.
Published in:
Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40966-8
By:
- Coffey, David G.;
- Maura, Francesco;
- Gonzalez-Kozlova, Edgar;
- Diaz-Mejia, J. Javier;
- Luo, Ping;
- Zhang, Yong;
- Xu, Yuexin;
- Warren, Edus H.;
- Dawson, Travis;
- Lee, Brian;
- Xie, Hui;
- Smith, Eric;
- Ciardiello, Amanda;
- Cho, Hearn J.;
- Rahman, Adeeb;
- Kim-Schulze, Seunghee;
- Diamond, Benjamin;
- Lesokhin, Alexander;
- Kazandjian, Dickran;
- Pugh, Trevor J.
Publication type:
Article
A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy.
Published in:
Leukemia & Lymphoma, 2022, v. 63, n. 14, p. 3488, doi. 10.1080/10428194.2022.2131417
By:
- Nath, Karthik;
- Shekarkhand, Tala;
- Salcedo, Meghan;
- Derkach, Andriy;
- Rueda, Siobhan;
- Chansakul, Aisara;
- Hulcrantz, Malin;
- Korde, Neha;
- Shah, Urvi A.;
- Tan, Carlyn;
- Chung, David J.;
- Lahoud, Oscar B.;
- Hassoun, Hani;
- Lesokhin, Alexander M.;
- Landau, Heather J.;
- Shah, Gunjan;
- Scordo, Michael;
- Giralt, Sergio A.;
- Usmani, Saad Z.;
- Roshal, Mikhail
Publication type:
Article
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study.
Published in:
Leukemia & Lymphoma, 2022, v. 63, n. 11, p. 2760, doi. 10.1080/10428194.2022.2095626
By:
- Mailankody, Sham;
- Salcedo, Meghan;
- Tavitian, Elizabet;
- Burge, Miranda;
- Korde, Neha;
- Hassoun, Hani;
- Lesokhin, Alexander;
- Lahoud, Oscar;
- Smith, Eric;
- Hultcrantz, Malin;
- Tan, Carlyn;
- Shah, Urvi;
- Devlin, Sean;
- Landgren, Ola
Publication type:
Article
Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma.
Published in:
Leukemia & Lymphoma, 2022, v. 63, n. 9, p. 2233, doi. 10.1080/10428194.2022.2068002
By:
- Kuo, Alyce M.;
- Hassoun, Hani;
- Shah, Urvi;
- Gordon, Allison;
- Hollmann, Travis J.;
- Landau, Heather J.;
- Lezcano, Cecilia;
- Mailankody, Sham;
- Tan, Carlyn C.;
- Lesokhin, Alexander M.;
- Markova, Alina
Publication type:
Article
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach.
Published in:
Leukemia & Lymphoma, 2022, v. 63, n. 9, p. 2126, doi. 10.1080/10428194.2022.2062347
By:
- Lahoud, Oscar B.;
- Landau, Heather;
- Nguyen, James;
- Devlin, Sean;
- Lendvai, Nikoletta;
- Weltz, Jonathan;
- Ayorinde, Tumininu;
- Chung, David J.;
- Lesokhin, Alexander M.;
- Kewalramani, Tarun;
- Korde, Neha;
- Mailankody, Sham;
- Landgren, Ola;
- Giralt, Sergio;
- Comenzo, Raymond L.;
- Hassoun, Hani
Publication type:
Article
Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity.
Published in:
2018
By:
- Tsakos, Ioanna;
- Alexander, Aeri;
- Lendvai, Nikoletta;
- Hassoun, Hani;
- Lesokhin, Alexander M.;
- Korde, Neha;
- Mailankody, Sham;
- Smith, Eric;
- Landgren, Ola;
- Schaffer, Wendy L.;
- Landau, Heather;
- Chung, David J.;
- Koehne, Guenther;
- Shah, Gunjan L.;
- Giralt, Sergio A.;
- Devlin, Sean M.;
- Patel, Minal;
- Ballagi, Andrea;
- Grundberg, Ida
Publication type:
Letter to the Editor
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.
Published in:
2018
By:
- Pianko, Matthew J.;
- Funt, Samuel A.;
- Page, David B.;
- Cattry, Deepika;
- Scott, Emma C.;
- Ansell, Stephen M.;
- Borrello, Ivan M.;
- Gutierrez, Martin;
- Lendvai, Nikoletta;
- Hassoun, Hani;
- Landgren, C. Ola;
- Lesokhin, Alexander M.
Publication type:
Letter to the Editor
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance.
Published in:
Leukemia & Lymphoma, 2017, v. 58, n. 12, p. 2962, doi. 10.1080/10428194.2017.1312382
By:
- Hassoun, Hani;
- Roshal, Mikhail;
- Sabari, Joshua;
- Nguyen, James;
- Gao, Qi;
- Devlin, Sean M.;
- Landau, Heather;
- Lendvai, Nikoletta;
- Chung, David J.;
- Lesokhin, Alexander M.;
- Korde, Neha;
- Mailankody, Sham;
- Dogan, Ahmet;
- Giralt, Sergio A.;
- Landgren, C. Ola
Publication type:
Article
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation.
Published in:
Leukemia & Lymphoma, 2017, v. 58, n. 8, p. 1823, doi. 10.1080/10428194.2016.1260126
By:
- Shah, Gunjan L.;
- Landau, Heather;
- Londono, Dory;
- Devlin, Sean M.;
- Kosuri, Satyajit;
- Lesokhin, Alexander M.;
- Lendvai, Nikoletta;
- Hassoun, Hani;
- Chung, David J.;
- Koehne, Guenther;
- Jhanwar, Suresh C.;
- Landgren, Ola;
- Levine, Ross;
- Giralt, Sergio A.
Publication type:
Article
Proteomic profiling in plasma cell disorders: a feasibility study.
Published in:
Leukemia & Lymphoma, 2017, v. 58, n. 7, p. 1757, doi. 10.1080/10428194.2016.1258699
By:
- Mailankody, Sham;
- Devlin, Sean M.;
- Korde, Neha;
- Lendvai, Nikoletta;
- Lesokhin, Alexander;
- Landau, Heather;
- Hassoun, Hani;
- Ballagi, Andrea;
- Ekman, Daniel;
- Chung, David J.;
- Patel, Minal;
- Koehne, Guenther;
- Giralt, Sergio;
- Landgren, Ola
Publication type:
Article
Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency*.
Published in:
Leukemia & Lymphoma, 2017, v. 58, n. 5, p. 1123, doi. 10.1080/10428194.2016.1239261
By:
- Ogunniyi, Adebayo;
- Rodriguez, Mabel;
- Devlin, Sean;
- Adel, Nelly;
- Landau, Heather;
- Chung, David J.;
- Lendvai, Nikoletta;
- Lesokhin, Alexander;
- Koehne, Guenther;
- Mailankody, Sham;
- Korde, Neha;
- Reich, Lilian;
- Landgren, Ola;
- Giralt, Sergio;
- Hassoun, Hani
Publication type:
Article
Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.
Published in:
Leukemia & Lymphoma, 2016, v. 57, n. 8, p. 1781, doi. 10.3109/10428194.2015.1121256
By:
- Landau, Heather;
- Wood, Kevin;
- Chung, David J.;
- Koehne, Guenther;
- Lendvai, Nikoletta;
- Hassoun, Hani;
- Lesokhin, Alexander;
- Hoover, Elizabeth;
- Zheng, Junting;
- Devlin, Sean M.;
- Giralt, Sergio
Publication type:
Article
Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease.
Published in:
Leukemia & Lymphoma, 2012, v. 53, n. 2, p. 275, doi. 10.3109/10428194.2011.606943
By:
- Landau, Heather;
- Pandit-Taskar, Neeta;
- Hassoun, Hani;
- Cohen, Adam;
- Lesokhin, Alex;
- Lendvai, Nikoletta;
- Drullinsky, Pamela;
- Schulman, Philip;
- Jhanwar, Suresh;
- Hoover, Elizabeth;
- Bello, Christina;
- Riedel, Elyn;
- Nimer, Stephen D.;
- Comenzo, Raymond L.
Publication type:
Article
Immunotherapy: A New Approach to Treating Multiple Myeloma with Daratumumab and Elotuzumab.
Published in:
2016
By:
- Afifi, Salma;
- Michael, Angela;
- Lesokhin, Alexander
Publication type:
journal article
Soluble B‐cell maturation antigen in multiple myeloma.
Published in:
American Journal of Hematology, 2024, v. 99, n. 4, p. 727, doi. 10.1002/ajh.27225
By:
- Costa, Bruno Almeida;
- Ortiz, Ricardo J.;
- Lesokhin, Alexander M.;
- Richter, Joshua
Publication type:
Article
Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
Published in:
American Journal of Hematology, 2023, v. 98, n. 3, p. 421, doi. 10.1002/ajh.26801
By:
- Pianko, Matthew J.;
- Tiutan, Timothy;
- Derkach, Andriy;
- Flynn, Jessica;
- Salvatore, Steven P.;
- Jaffer‐Sathick, Insara;
- Rossi, Adriana C.;
- Lahoud, Oscar;
- Hultcrantz, Malin;
- Shah, Urvi A.;
- Maclachlan, Kylee;
- Chung, David J.;
- Shah, Gunjan L.;
- Landau, Heather J.;
- Korde, Neha;
- Mailankody, Sham;
- Lesokhin, Alexander M.;
- Tan, Carlyn;
- Scordo, Michael;
- Jaimes, Edgar A.
Publication type:
Article
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience.
Published in:
American Journal of Hematology, 2022, v. 97, n. 7, p. E276, doi. 10.1002/ajh.26580
By:
- Mohan, Meera;
- Becnel, Melody Renee;
- Shah, Urvi A.;
- Dong, Huaying;
- Gundarlapalli, Sravani;
- Peterson, Timothy;
- Orozco, Jennifer S.;
- Horowitz, Sandra;
- Chhabra, Saurabh;
- Dhakal, Binod;
- Thanendrarajan, Sharmilan;
- Radhakrishnan, Sabarinath Venniyil;
- Al Hadidi, Samer;
- Tan, Carlyn;
- Mailankody, Sham;
- Hultcrantz, Malin;
- Korde, Neha;
- Hassoun, Hani;
- Lesokhin, Alexander M.;
- Thomas, Sheeba K.
Publication type:
Article
Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice‐weekly carfilzomib (45 and 56 mg/m<sup>2</sup>) in combination with lenalidomide and dexamethasone.
Published in:
American Journal of Hematology, 2021, v. 96, n. 6, p. E193, doi. 10.1002/ajh.26150
By:
- Korde, Neha;
- Mastey, Donna;
- Tavitian, Elizabet;
- Mailankody, Sham;
- Lesokhin, Alexander;
- Hassoun, Hani;
- Smith, Eric L.;
- Lendvai, Nikoletta;
- Hultcrantz, Malin;
- Shah, Urvi;
- Tan, Carlyn;
- Lu, Sydney;
- Diamond, Benjamin;
- Salcedo, Meghan;
- Werner, Kelly;
- Chung, David J.;
- Scordo, Michael;
- Shah, Gunjan L.;
- Lahoud, Oscar;
- Landau, Heather
Publication type:
Article
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22140-0
By:
- Oben, Bénedith;
- Froyen, Guy;
- Maclachlan, Kylee H.;
- Leongamornlert, Daniel;
- Abascal, Federico;
- Zheng-Lin, Binbin;
- Yellapantula, Venkata;
- Derkach, Andriy;
- Geerdens, Ellen;
- Diamond, Benjamin T.;
- Arijs, Ingrid;
- Maes, Brigitte;
- Vanhees, Kimberly;
- Hultcrantz, Malin;
- Manasanch, Elisabet E.;
- Kazandjian, Dickran;
- Lesokhin, Alexander;
- Dogan, Ahmet;
- Zhang, Yanming;
- Mikulasova, Aneta
Publication type:
Article
Implementation of the Protection Optimization for Normalization of Radiation Conditions in BSKH-3A.
Published in:
Atomic Energy, 2016, v. 120, n. 5, p. 342, doi. 10.1007/s10512-016-0141-8
By:
- Sukhoruchkin, A.;
- Stepennov, B.;
- Fedoseenkov, A.;
- Kulikov, K.;
- Zaochinskii, S.;
- Ivanov, A.;
- Lesokhin, B.
Publication type:
Article